One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:27
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:15
Amgen’s $28 Billion Horizon Buy Will Be Challenged by FTC
Amgen Inc.’s $27.8 billion deal to buy Horizon Therapeutics Plc, the largest in the biotechnology company’s history, will
2023-05-16 17:47